# EDGAR Filing Document

**Accession Number:** 0001410098
**File Stem:** 0001213900-25-097097
**Filing Date:** 2025-10
**Character Count:** 2798
**Document Hash:** 8d192353761a32d7e3eb4b3a956833d9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-097097.hdr.sgml**: 20251007

**ACCESSION NUMBER**: 0001213900-25-097097

**CONFORMED SUBMISSION TYPE**: RW

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251007

**DATE AS OF CHANGE**: 20251007

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CorMedix Inc.
- **CENTRAL INDEX KEY:** 0001410098
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** RW

**SEC ACT:**
- **SEC FILE NUMBER:** 333-290721
- **FILM NUMBER:** 251380533

**BUSINESS ADDRESS:**
- **STREET 1:** 300 CONNELL DRIVE
- **STREET 2:** SUITE 4200
- **CITY:** BERKELEY HEIGHTS
- **STATE:** NJ
- **ZIP:** 07922
- **BUSINESS PHONE:** 908-517-9500

**MAIL ADDRESS:**
- **STREET 1:** 300 CONNELL DRIVE
- **STREET 2:** SUITE 4200
- **CITY:** BERKELEY HEIGHTS
- **STATE:** NJ
- **ZIP:** 07922

**CorMedix Inc.**

**300 Connell Drive, Suite 4200**

**Berkeley Heights, NJ 07922**

October 7, 2025

Division of Corporation Finance

Securities & Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549-3561

---

| | |
|:---|:---|
| Re: | CorMedix Inc. (CIK: 0001410098) |
|  | Form S-3ASR |
|  | Filed on October 6, 2025 |
|  | File No. 333-290721 |

---

Pursuant to Rule 477 under the Securities Act of 1933, as amended, CorMedix Inc. (the "<u>Registrant</u>") hereby requests the withdrawal, effective immediately, of Registration Statement on Form S-3ASR, File No. 333-290721 (the "<u>Registration Statement</u>"), which was originally filed by the Registrant with the Securities and Exchange Commission (the "<u>Commission</u>") on October 6, 2025. The Registration Statement inadvertently omitted current dates from the exhibits incorporated into such filing. The Registration Statement will be refiled on EDGAR promptly, with the corrected dates for such exhibits.

The Company confirms that no securities have been sold under the Registration Statement. The Company understands that, pursuant to Rule 477(b) under the Securities Act, this application for withdrawal will be effective at the time filed with the Commission unless, within fifteen calendar days after the filing, the Commission notifies the Company that the application for withdrawal will not be granted.

Please direct any questions or comments regarding this correspondence to Andrew Marmer of Willkie Farr & Gallagher, LLP, at (212) 728-8847. Thank you for your assistance in this matter.

---

| | |
|:---|:---|
| Respectfully submitted, | Respectfully submitted, |
| By: | */s/ Beth Zelnick Kaufman* |
| Name: | Beth Zelnick Kaufman |
| Title: | Chief Legal and Compliance Officer and Corporate Secretary |

---